These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 38554236)
1. A prospective study of smoking-related white blood cell DNA methylation markers and risk of bladder cancer. Vermeulen R; Bodinier B; Dagnino S; Wada R; Wang X; Silverman D; Albanes D; Freedman N; Rahman M; Bell D; Chadeau-Hyam M; Rothman N Eur J Epidemiol; 2024 Apr; 39(4):393-407. PubMed ID: 38554236 [TBL] [Abstract][Full Text] [Related]
2. LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants. Andreotti G; Karami S; Pfeiffer RM; Hurwitz L; Liao LM; Weinstein SJ; Albanes D; Virtamo J; Silverman DT; Rothman N; Moore LE Epigenetics; 2014 Mar; 9(3):404-15. PubMed ID: 24316677 [TBL] [Abstract][Full Text] [Related]
3. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Moore LE; Pfeiffer RM; Poscablo C; Real FX; Kogevinas M; Silverman D; García-Closas R; Chanock S; Tardón A; Serra C; Carrato A; Dosemeci M; García-Closas M; Esteller M; Fraga M; Rothman N; Malats N Lancet Oncol; 2008 Apr; 9(4):359-66. PubMed ID: 18339581 [TBL] [Abstract][Full Text] [Related]
4. LINE1 methylation levels in pre-diagnostic leukocyte DNA and future renal cell carcinoma risk. Karami S; Andreotti G; Liao LM; Pfeiffer RM; Weinstein SJ; Purdue MP; Hofmann JN; Albanes D; Mannisto S; Moore LE Epigenetics; 2015; 10(4):282-92. PubMed ID: 25647181 [TBL] [Abstract][Full Text] [Related]
5. Differential DNA methylation in blood as a mediator of the association between cigarette smoking and bladder cancer risk among postmenopausal women. Jordahl KM; Phipps AI; Randolph TW; Tindle HA; Liu S; Tinker LF; Kelsey KT; White E; Bhatti P Epigenetics; 2019 Nov; 14(11):1065-1073. PubMed ID: 31232174 [TBL] [Abstract][Full Text] [Related]
6. DNA methylation profiles delineate etiologic heterogeneity and clinically important subgroups of bladder cancer. Wilhelm-Benartzi CS; Koestler DC; Houseman EA; Christensen BC; Wiencke JK; Schned AR; Karagas MR; Kelsey KT; Marsit CJ Carcinogenesis; 2010 Nov; 31(11):1972-6. PubMed ID: 20802236 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic Signatures of Cigarette Smoking. Joehanes R; Just AC; Marioni RE; Pilling LC; Reynolds LM; Mandaviya PR; Guan W; Xu T; Elks CE; Aslibekyan S; Moreno-Macias H; Smith JA; Brody JA; Dhingra R; Yousefi P; Pankow JS; Kunze S; Shah SH; McRae AF; Lohman K; Sha J; Absher DM; Ferrucci L; Zhao W; Demerath EW; Bressler J; Grove ML; Huan T; Liu C; Mendelson MM; Yao C; Kiel DP; Peters A; Wang-Sattler R; Visscher PM; Wray NR; Starr JM; Ding J; Rodriguez CJ; Wareham NJ; Irvin MR; Zhi D; Barrdahl M; Vineis P; Ambatipudi S; Uitterlinden AG; Hofman A; Schwartz J; Colicino E; Hou L; Vokonas PS; Hernandez DG; Singleton AB; Bandinelli S; Turner ST; Ware EB; Smith AK; Klengel T; Binder EB; Psaty BM; Taylor KD; Gharib SA; Swenson BR; Liang L; DeMeo DL; O'Connor GT; Herceg Z; Ressler KJ; Conneely KN; Sotoodehnia N; Kardia SL; Melzer D; Baccarelli AA; van Meurs JB; Romieu I; Arnett DK; Ong KK; Liu Y; Waldenberger M; Deary IJ; Fornage M; Levy D; London SJ Circ Cardiovasc Genet; 2016 Oct; 9(5):436-447. PubMed ID: 27651444 [TBL] [Abstract][Full Text] [Related]
8. Distinct Epigenetic Effects of Tobacco Smoking in Whole Blood and among Leukocyte Subtypes. Su D; Wang X; Campbell MR; Porter DK; Pittman GS; Bennett BD; Wan M; Englert NA; Crowl CL; Gimple RN; Adamski KN; Huang Z; Murphy SK; Bell DA PLoS One; 2016; 11(12):e0166486. PubMed ID: 27935972 [TBL] [Abstract][Full Text] [Related]
9. DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer. Marsit CJ; Koestler DC; Christensen BC; Karagas MR; Houseman EA; Kelsey KT J Clin Oncol; 2011 Mar; 29(9):1133-9. PubMed ID: 21343564 [TBL] [Abstract][Full Text] [Related]
10. Smoking-associated DNA methylation markers predict lung cancer incidence. Zhang Y; Elgizouli M; Schöttker B; Holleczek B; Nieters A; Brenner H Clin Epigenetics; 2016; 8():127. PubMed ID: 27924164 [TBL] [Abstract][Full Text] [Related]
11. Prediagnostic White Blood Cell DNA Methylation and Risk of Breast Cancer in the Prostate Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Cohort. Sturgeon SR; Sela DA; Browne EP; Einson J; Rani A; Halabi M; Kania T; Keezer A; Balasubramanian R; Ziegler RG; Schairer C; Kelsey KT; Arcaro KF Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1575-1581. PubMed ID: 34108140 [TBL] [Abstract][Full Text] [Related]
12. Association of secondhand smoke exposures with DNA methylation in bladder carcinomas. Wilhelm-Benartzi CS; Christensen BC; Koestler DC; Houseman EA; Schned AR; Karagas MR; Kelsey KT; Marsit CJ Cancer Causes Control; 2011 Aug; 22(8):1205-13. PubMed ID: 21660454 [TBL] [Abstract][Full Text] [Related]
13. Telomere length in white blood cell DNA and lung cancer: a pooled analysis of three prospective cohorts. Seow WJ; Cawthon RM; Purdue MP; Hu W; Gao YT; Huang WY; Weinstein SJ; Ji BT; Virtamo J; Hosgood HD; Bassig BA; Shu XO; Cai Q; Xiang YB; Min S; Chow WH; Berndt SI; Kim C; Lim U; Albanes D; Caporaso NE; Chanock S; Zheng W; Rothman N; Lan Q Cancer Res; 2014 Aug; 74(15):4090-8. PubMed ID: 24853549 [TBL] [Abstract][Full Text] [Related]
14. Individual and joint contributions of genetic and methylation risk scores for enhancing lung cancer risk stratification: data from a population-based cohort in Germany. Yu H; Raut JR; Schöttker B; Holleczek B; Zhang Y; Brenner H Clin Epigenetics; 2020 Jun; 12(1):89. PubMed ID: 32552915 [TBL] [Abstract][Full Text] [Related]
15. AHRR methylation in heavy smokers: associations with smoking, lung cancer risk, and lung cancer mortality. Grieshober L; Graw S; Barnett MJ; Thornquist MD; Goodman GE; Chen C; Koestler DC; Marsit CJ; Doherty JA BMC Cancer; 2020 Sep; 20(1):905. PubMed ID: 32962699 [TBL] [Abstract][Full Text] [Related]
16. Genome-Wide DNA Methylation in Prediagnostic Blood and Bladder Cancer Risk in the Women's Health Initiative. Jordahl KM; Randolph TW; Song X; Sather CL; Tinker LF; Phipps AI; Kelsey KT; White E; Bhatti P Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):689-695. PubMed ID: 29540343 [No Abstract] [Full Text] [Related]
17. A case-control study of smoking and bladder cancer risk: emergent patterns over time. Baris D; Karagas MR; Verrill C; Johnson A; Andrew AS; Marsit CJ; Schwenn M; Colt JS; Cherala S; Samanic C; Waddell R; Cantor KP; Schned A; Rothman N; Lubin J; Fraumeni JF; Hoover RN; Kelsey KT; Silverman DT J Natl Cancer Inst; 2009 Nov; 101(22):1553-61. PubMed ID: 19917915 [TBL] [Abstract][Full Text] [Related]
18. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Samanic C; Kogevinas M; Dosemeci M; Malats N; Real FX; Garcia-Closas M; Serra C; Carrato A; García-Closas R; Sala M; Lloreta J; Tardón A; Rothman N; Silverman DT Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1348-54. PubMed ID: 16835335 [TBL] [Abstract][Full Text] [Related]
19. Distinct DNA methylation epigenotypes in bladder cancer from different Chinese sub-populations and its implication in cancer detection using voided urine. Chen PC; Tsai MH; Yip SK; Jou YC; Ng CF; Chen Y; Wang X; Huang W; Tung CL; Chen GC; Huang MM; Tong JH; Song EJ; Chang DC; Hsu CD; To KF; Shen CH; Chan MW BMC Med Genomics; 2011 May; 4():45. PubMed ID: 21599969 [TBL] [Abstract][Full Text] [Related]
20. Tobacco smoking differently influences cell types of the innate and adaptive immune system-indications from CpG site methylation. Bauer M; Fink B; Thürmann L; Eszlinger M; Herberth G; Lehmann I Clin Epigenetics; 2015; 7():83. PubMed ID: 27493699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]